NEW YORK and SHANGHAI, Feb. 26,
2020 /PRNewswire/ -- Cellular Biomedicine Group, Inc.
(NASDAQ: CBMG) ("CBMG" or the "Company"), a biopharmaceutical firm
engaged in the drug development of immunotherapies for cancer and
stem cell therapies for degenerative diseases, today announced that
it will release its financial results for the fourth quarter and
full year ended December 31, 2019
after the market closes on Friday, February
28, 2020.
The Company will host a conference call and webcast with the
investment community on Friday, February
28th at 4:30 p.m. Eastern
Time, featuring remarks by Tony
Liu, Executive Director, CEO and CFO of CBMG.
|
What:
|
Cellular Biomedicine
Fourth Quarter and Full Year 2019 Results Conference
Call
|
|
|
|
Date:
|
Friday, February 28,
2020
|
|
|
|
Time:
|
4:30 p.m. Eastern
Time
|
|
|
|
Live
Call:
|
Toll-Free:
1-877-423-9813
International:
1-201-689-8573
|
|
|
|
Webcast:
|
http://public.viavid.com/index.php?id=138289
|
|
|
|
Replay:
|
Toll-Free:
1-844-512-2921
International:
1-412-317-6671
Conference ID:
13699688
(Available
approximately two hours after the completion of the live call until
11:59 p.m. ET on March 13, 2020)
|
About Cellular Biomedicine Group, Inc.
Cellular Biomedicine Group, Inc. is a biopharmaceutical firm
engaged in the drug development of immunotherapies for cancer and
stem cell therapies for degenerative diseases. For more
information, please visit https://www.cellbiomedgroup.com/.
For more information, please contact:
Company Contact:
Derrick C. Li
Head of Strategy and Investor Relations, CBMG
Phone: 917-717-0994
Email: derrick.li@cellbiomedgroup.com
Investor Contact:
Valter Pinto / Allison Soss
KCSA Strategic Communications
Phone: 212-896-1254 / 212-896-1267
Email: cellbiomed@kcsa.com
View original content to download
multimedia:http://www.prnewswire.com/news-releases/cellular-biomedicine-group-to-report-fourth-quarter-and-full-year-2019-results-on-february-28-2020-301011725.html
SOURCE Cellular Biomedicine Group, Inc.